- CA$372.19m
- CA$294.85m
- CA$320.59m
Cannabis stocks rise on report saying Trump may ease curbs this week
Cannabis stocks rise after Trump considers executive order to reclassify marijuana
Cannabis stocks rise after Trumps considers executive order to reclassify marijuana
Explainer: How US marijuana reclassification could help cannabis companies
Pot stocks climb on report Trump considers easing marijuana restrictions
Brief: Rubicon Organics Announces Appointment Of Glen Ibbott As CFO
Aurora Cannabis Q2 revenue misses estimates despite 15% medical cannabis growth
Cannabis stocks surge after Trump endorses cannabidiol for senior healthcare (updated)
Cannabis stocks surge after Trump endorses cannabidiol for senior healthcare
Brief: Aurora Announces Investment Into German Manufacturing Facility
Explainer: How US marijuana reclassification could help cannabis companies
Pot stocks climb on report Trump considers reclassifying marijuana as less dangerous
Aurora Cannabis Q1 revenue up 17%, adjusted EBITDA rises 209%
Brief: Aurora Cannabis Denies Discussions With Medleaf Therapeutics or Medipharm GmbH
Brief: Aurora Cannabis denies news of acquisition of Medleaf Therapeutics
Aurora Cannabis falls despite upbeat Q4 results as sales forecast weighs
Aurora Cannabis falls despite upbeat Q4 results as sales forecast weighs
Aurora Cannabis rises on Q4 revenue beat
Brief: Rubicon Organics Announces Appointment Of Glen Ibbott As Interim CFO